Key PointsA novel methodology is presented to compare ictal high‐frequency oscillations and interictal FDG‐PETIctal HFOs recorded by SEEG are more likely to occur in regions showing hypometabolism, in temporal lobe epilepsy onlyRegions showing ictal oscillations at frequencies in the beta band and below do not show significant interictal hypometabolismInterictal FDG‐PET hypometabolism and ictal HFOs may highlight common pathophysiologic mechanisms in temporal lobe epilepsy

 {#epi13592-sec-0006}

Interictal \[18F\]fluorodeoxyglucose--positron emission tomography (FDG‐PET) is useful in the presurgical evaluation of patients with drug‐resistant focal epilepsy.[1](#epi13592-bib-0001){ref-type="ref"} Hypometabolism overlies the seizure‐onset zone (SOZ) with a sensitivity of 86--90% in temporal lobe epilepsy (TLE) and of 45--60% in extra‐TLE.[2](#epi13592-bib-0002){ref-type="ref"}, [3](#epi13592-bib-0003){ref-type="ref"}, [4](#epi13592-bib-0004){ref-type="ref"}, [5](#epi13592-bib-0005){ref-type="ref"} Although it is a tool that has proven to be clinically useful, there is as yet no pathophysiologic explanation for the hypometabolism found in epilepsy. Recent findings suggest that FDG‐PET is reliable for localizing type 2 focal cortical dysplasia (FCD),[6](#epi13592-bib-0006){ref-type="ref"}, [7](#epi13592-bib-0007){ref-type="ref"} a highly epileptogenic lesion; however, it is not known whether the metabolic anomalies detected by FDG‐PET result from the same pathophysiologic process as the electrical anomalies seen in epilepsy.[8](#epi13592-bib-0008){ref-type="ref"}, [9](#epi13592-bib-0009){ref-type="ref"} The goal of this study is to determine whether electrical findings at seizure onset and interictal metabolic patterns can improve understanding of the pathophysiology of focal epilepsy.

The epileptogenicity map, a statistical parametric three‐dimensional (3D) map quantifying high‐frequency oscillations (HFOs) at seizure onset, may help gain a better understanding of the relationship between FDG‐PET metabolic patterns and the electrical activity recorded by intracranial electrodes. This tool is based on ictal HFOs (iHFOs) which are recorded by stereo‐electroencephalography (SEEG) at seizure onset, indicating the areas of high epileptogenicity.[10](#epi13592-bib-0010){ref-type="ref"} The iHFOs are isolated and quantified by computerized analysis for each intracranial electrode. An epileptogenicity index is calculated for the voxels located near the intracerebral electrodes. This index represents the likelihood that a region has high epileptogenicity. It is shown as a color scale overlying the magnetic resonance imaging (MRI) of the patient\'s brain. The epileptogenicity map has good reproducibility and sensitivity[11](#epi13592-bib-0011){ref-type="ref"} and has proved to be helpful to better understand the epileptogenic brain networks subserving different kinds of focal seizures.[12](#epi13592-bib-0012){ref-type="ref"}, [13](#epi13592-bib-0013){ref-type="ref"}, [14](#epi13592-bib-0014){ref-type="ref"} The map allows for a precise quantitative analysis of the SEEG signals and a direct comparison with other imaging tools,[12](#epi13592-bib-0012){ref-type="ref"} such as FDG‐PET scans.

This study used the epileptogenicity maps to compare the intracranial EEG activity with the interictal metabolism derived from FDG‐PET. iHFOs were selected as the marker of epileptogenic electrical activity, and two bands of lower frequencies, 2--7 Hz and 8--20 Hz, were selected as controls. The frequencies of the iHFOs varied from patient to patient, as they were individually selected based on the interval of frequencies with the highest power during seizure onset. FDG‐PET metabolism was analyzed semiquantitatively with a voxel‐based approach, by comparing the levels of metabolism to that of each patient\'s cerebellum taken as a reference. The association found helps gain a better understanding of the pathophysiologic relationship between the electrical and metabolic changes in epilepsy. The goal of this study was to determine whether iHFOs, as a biomarker of epileptogenicity, and interictal hypometabolism are anatomically related using a method that allows for precise quantification of anatomic and physiologic data.

Methods {#epi13592-sec-0007}
=======

Patient information {#epi13592-sec-0008}
-------------------

Patients with intractable focal epilepsy followed at the Centre Hospitalier Universitaire de Grenoble‐Alpes (CHUGA), who required a high‐resolution MRI, video‐EEG monitoring, an FDG‐PET scan, and SEEG as part of their presurgical evaluation during the 2008--2012 period, were retrospectively selected for this study. Thirty‐seven patients were included in the study based on these criteria. Of these, 15 patients had TLE and 22 patients had extra‐TLE. This was determined from a combined analysis of the ictal clinical semiology, EEG, MRI, SEEG, and FDG‐PET. As summarized in Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}, the group of TLE patients was atypical and nonhomogenous: nine patients had a mesial predominance of seizure onset (patients 1--9), four patients had a neocortical predominance (patients 10--13), and two patients were classified as "temporal plus" (patients 14--15). Fifteen patients were MRI positive and 22 patients were MRI negative for brain anomalies. Surgical resection was performed in 31 patients, and after a mean postoperative follow‐up of 18 months, seizure outcome as assessed by Engel\'s classification[15](#epi13592-bib-0015){ref-type="ref"} showed that 17 patients were in class I (55%), 5 in class II (16%), 4 in class III (13%), and 5 in class IV (16%).

###### 

Patients' characteristics

  Patient   Age at SEEG   Sex   Epilepsy onset   Seizure frequency   MRI findings                                  FDG‐PET scan visual findings                      Electrode placement   Surgery                     Histology     Postoperative follow‐up   Outcome^a^
  --------- ------------- ----- ---------------- ------------------- --------------------------------------------- ------------------------------------------------- --------------------- --------------------------- ------------- ------------------------- ------------
  1         52            F     6y               Monthly (2--3/m)    N                                             R T pole                                          12 R + 2 L            R T anteromesial            FCD IA        \>1y                      IA
  2         32            M     13y              Monthly (3--4/m)    N                                             L T mesial                                        11 L + 2 R            L T anteromesial            FCD IA        5 m                       IA
  3         41            F     22y              Weekly (5--6/m)     N                                             F T + F Basal                                     11 L + 3 R            L T anteromesial            FCD IA        \>2y                      ID
  4         35            M     27y              Daily               R P mesial gliosis                            R P posterosuperior + mesial                      15 R                  R T anteromesial            Gliosis       \>2y                      II
  5         16            F     15y              Weekly (2/w)        N                                             L T basal + posterior area                        9 R + 6 L             R T anteromesial            HS            \>2y                      IA
  6         26            F     20y              Monthly (2/m)       N                                             L F basolateral \> L T1 \> L T pole               14 L                  L T anteromesial            Normal        \>1y                      IA
  7         32            F     29.5y            Weekly              N                                             R T anteromesial                                  15 R                  R T anteromesial            Not found     \>2y                      IA
  8         35            F     13y              Monthly             N                                             R T pole                                          12 R                  R T anteromesial            Nonspecific   \>2y                      III
  9         26            F     2y               Monthly             N                                             L T pole                                          4R + 10 L             No surgery                  NA            NA                        NA
  10        38            F     8y               Daily               L posterior T‐basal hypersignal               L T mesial                                        12 L                  L T‐basal                   FCD IA        1y                        III
  11        52            M     25y              Weekly (15--20/m)   L posterior T‐basal hypersignal               L T‐O (+ L hemispheric)                           14 L                  L T basal                   FCD IIIB      \>1y                      II
  12        18            F     10y              Monthly (3/m)       N                                             L T pole                                          12D + 2G              L temporobasal              Nonspecific   \>2y                      IV
  13        40            M     28y              Weekly              L thalamic cyst                               L T posteromesial                                 6R + 10L              L basal temporal            FCD IA        \>1y                      II
  14        34            M     34y              Monthly             N                                             R F basal + orbitary + \< hippocampal + F polar   10 L                  L T anteromesial            HS            \>2y                      IB
  15        22            M     6y               Monthly (2--3/m)    N                                             L temporal pole + mesial                          13 L                  L temporal                  Gliosis       \>2y                      IA
  16        23            F     9y               Monthly             N                                             L paracentral lobule                              15 L                  L SMA                       FCD IIA       \>2y                      IVB
  17        29            M     17y              Weekly              N                                             F bilateral                                       10 R + 7 L            No surgery                  NA            NA                        NA
  18        35            M     31y              Weekly              N                                             L T pole + perisylvian                            12 R + 5 L            R anterior insula           FCD IIA       8 m                       IIB
  19        32            M     29y              Monthly             N                                             L T‐P (+ bilateral multifocal)                    16 R                  R prefrontal                FCD IA        \>1y                      ID
  20        23            F     9y               Weekly              L thalamic stroke                             Bilateral (L\>R) hippocampus + T pole             15 L                  L postcingulate             Nonspecific   \>2y                      IA
  21        29            M     12y              Monthly             Bilateral F basal posttraumatic scar (R\>L)   R F                                               15 R + 3 L            R premotor + prefrontal     Gliosis       \>1y                      IA
  22        20            M     17y              Monthly             N                                             L T anteromesial + L precuneus                    12 L + 4 R            L ventral premotor          Nonspecific   8 m                       IV
  23        19            F     12y              Daily               N                                             R F premotor (F1 \> F2)                           15 R                  R F premotor                FCD IIB       \>1y                      IA
  24        15            F     4y               Daily               N                                             R F anteromesial                                  14 R                  R F mesial                  Nonspecific   \>2y                      IA
  25        11            F     6.5y             Monthly (1/m)       L premotor FCD                                L premotor                                        16 L                  L premotor                  FCD IIA       1y                        ID
  26        17            M     5y               Monthly (1/m)       L mesial O FCD                                R T pole + T‐O                                    8 R + 8 L             L O mesial                  FCD IA        \>2y                      IA
  27        31            F     21y              Monthly (1/m)       N                                             R F mesial \> L P operculum                       14 R                  R prefrontal                Nonspecific   \>1y                      III
  28        44            M     33y              Weekly (1/w)        L motor opercular FCD                         L perirolandic \> L F polar                       17 L                  L motor operculum           FCD IA        \>1y                      IV
  29        22            M     9y               Daily               N                                             R T‐perisylvian                                   14 R + 7 L            R posterior insula          FCD IB        \>2y                      IIB
  30        6             M     2y               Monthly             R dorsal premotor FCD                         Inconclusive                                      13 R                  R dorsal premotor           FCD IIB       \>2y                      IA
  31        31            F     25.5y            Daily               L inferior occipital surgery                  L O laterosuperior                                13 L + 3 R            L occipitotemporal          FCD IA        \>2y                      IV
  32        46            M     43y              Weekly              R HS                                          R T                                               13 R                  R F basal + F‐P operculum   FCD IIIA      \>1y                      III
  33        19            M     15y              Daily               N                                             Normal                                            8R + 8L               No surgery                  NA            NA                        NA
  34        19            F     5y               Daily               N                                             L T anterior                                      3R + 14 L             No surgery                  NA            NA                        NA
  35        21            F     14y              Monthly (3/m)       Hippocampal bilateral nodular heterotopy      R T posteromesial+ precuneus, thalamus            13 R + 3 L            No surgery                  NA            NA                        NA
  36        26            M     10y              Daily               N                                             R T pole                                          14 G                  R temporooccipital          FCD IA        8 m                       IA
  37        22            F     10y              Weekly              L rolandic FCD                                L F polar + F basal                               10 L                  No surgery                  NA            NA                        NA

^a^ according to Engel\'s classification; y, year; m, month; w, week; N, negative; R, right; L, left; T, temporal; F, frontal; O, occipital; P, parietal; FCD, focal cortical dysplasia; HS, hippocampal sclerosis; Na, not applicable.
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FDG‐PET study {#epi13592-sec-0009}
-------------

### Data acquisition {#epi13592-sec-0010}

The FDG‐PET scans were acquired either at the Department of Nuclear Medicine of CHUGA or at the CERMEP facility (Lyon). Patients fasted for a minimum of 6 h prior to the scan. The scans were not performed if patients had a seizure within the last 12 h, which was determined by interviewing patients and/or caregivers. Female patients of reproductive age were evaluated to ensure that they were not pregnant. In supine and resting patients, a dose of FDG corresponding to approximately 1.85 MBq/kg was injected 30--40 min prior to performing the scan. During the scans, patients were instructed to lie still and were clinically monitored for seizure activity. Scanning lasted approximately 10 min. The PET scanners were a TEP‐CT GE Discovery 690 scanner (CHUGA) or a SIEMENS HR+ (CERMEP). The scans were acquired in 3D mode with an axial resolution of 2.73 mm from the center at the CHUGA and 4.1 mm from the center at the CERMEP. Data were reconstructed using a 3D ordered subset expectation maximization algorithm (OSEM‐3D; 2 iterations, 24 subsets, 6.4 mm filter at CHUGA) or a 3D backprojection of filtered projections algorithm (Hanning filter 0.5 mm, image 128\*128 at CERMEP) with attenuation correction and time‐of‐flight. Voxel size was 1 mm and slice thickness was 3.27 mm (CHUGA) or 2.43 mm (CERMEP). The attending specialists performed 3D reorientation and visual analysis of the scans (summarized in Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}).

### Image processing {#epi13592-sec-0011}

The images were processed using Statistical Parametric Mapping software (SPM12, Wellcome Department of Imaging Neuroscience, [www.fil.ion.ucl.ac.uk/spm12](http://www.fil.ion.ucl.ac.uk/spm12)). T1‐MRI and PET images were first co‐registered. Spatial normalization onto the SPM12 T~1~‐MRI brain template in the Montreal Neurological Institute (MNI) referential was computed from T~1~‐MRI and applied to all images. Only the voxels that were part of the gray matter were kept in the analysis of PET images by thresholding at 0.4 the mask image of gray matter (grey.nii) produced by SPM12 unified segmentation procedure.[16](#epi13592-bib-0016){ref-type="ref"} To reduce intersubject variance before performing group analysis, the voxel value of each patient\'s FDG‐PET scan was divided by the average level of metabolism measured in the cerebellum.[17](#epi13592-bib-0017){ref-type="ref"} Before doing so, an expert visually assessed all images to ensure no metabolic changes in the cerebellum. Because the cerebellum is generally hypometabolic in comparison with the rest of the brain, a value slightly \>1 was given for each voxel. The image obtained was smoothed using a 3D isotropic Gaussian kernel of 3 mm in width.

SEEG investigation {#epi13592-sec-0012}
------------------

### Electrode implantation and position {#epi13592-sec-0013}

Patients were implanted with 10--21 electrodes (Dixi Medical, Besançon, France; diameter: 0.8 mm; 10--18 contacts, 2 mm long, and 1.5 mm apart) in stereotactic condition in regions that could correspond to the seizure‐onset zone (SOZ) based on previous investigations. Determination of the anatomic volume of the electrical activity recorded was done by interpolation of the values over a 5 mm radius of each electrode contact and a subsequent 3D linear interpolation for each voxel up to 10 mm away from the electrode contact. Electrode position was determined with a postimplantation T~1~‐weighted MRI co‐registered with the preimplantation MRI. The images were normalized using SPM12 software on the MNI (McGill University, Canada) referential.

### SEEG recordings {#epi13592-sec-0014}

Intracerebral recordings were conducted extraoperatively using an audio‐video‐EEG monitoring system (Micromed, Treviso, Italy) that allowed recording simultaneously up to 128 contacts, with a sampling rate of 512 Hz, and an acquisition band‐pass filter between 0.1 and 200 Hz. SEEG activity was considered between contiguous contacts at different levels along the axis of each electrode, and analysis of video‐SEEG traces was done visually to identify seizure‐onset times.

### Epileptogenicity mapping {#epi13592-sec-0015}

Electrical activity during and between seizures was recorded and analyzed using epileptogenicity mapping.[11](#epi13592-bib-0011){ref-type="ref"} The aim of the epileptogenicity mapping was to isolate the regions likely to produce iHFOs, which in this population generally remained around 80--140 Hz. The methodology was fully detailed in Ref. 11, and herein we present the main steps. A baseline void of any epileptic activity and of any artifact of at least 20 s was chosen within the 5 min preceding the seizure. The seizure onset of 4 s duration was isolated visually for all seizures recorded for each patient. This epoch of 4 s was determined by taking into account the timing of the clinical onset of the seizure, which was noted following revision of the video recording of the patients having the seizure, and the visual change of SEEG activity. Various patterns helped define the seizure‐onset zone: (1) low‐voltage fast activity over 20 Hz; (2) recruiting fast discharge (around 10 Hz or more) of spikes or polyspikes; and (3) rhythmic activity (around 10 Hz) of low amplitude.[11](#epi13592-bib-0011){ref-type="ref"} The placement of the seizure‐onset period did not take into account isolated or repetitive spikes at lower frequencies that might have preceded or started with few seizures in this group of patients, because this pattern could occur interictally without giving rise to any electroclinical seizures. For three patients, the duration of the onset period was reduced to 3 s because seizures were shorter. Figure [1](#epi13592-fig-0001){ref-type="fig"} shows an example of seizure onsets, as visually defined by simultaneous inspection of all recorded channels.

![Examples of single bipolar SEEG recordings in 10 patients (left: TLE; right: extra‐TLE) showing the diversity of seizure‐onset dynamics (time = 0 s). Visual definition of seizure onset was based on the careful inspection of all SEEG channels simultaneously (not shown here) and the presence of fast oscillations and/or repetitive spikes followed or concomitant to fast activity.](EPI-57-2045-g001){#epi13592-fig-0001}

The SEEG signals of each seizure were transformed into the time‐frequency space that was relevant to the patient\'s epilepsy, that is, −20 to 10 s and 1--130 Hz where time origin is seizure onset. The band of interest in high frequencies was selected based on visual analysis of power transforms. It varied from patient to patient (average, 81--139 Hz; lowest, 30--60 Hz; highest, 160--210 Hz). A log transform was applied to obtain data distribution that better resembled normal distribution, and images of ictal power were produced using local spatial projection of SEEG values on patient\'s cortical surface and smoothing with an isotropic Gaussian kernel of 3 mm in width. Statistical analysis was then performed in SPM12 via a standard two‐sample *t*‐test on the images, which determined the epileptogenicity index by comparing the seizure and baseline values. When several seizures were available for the same patient, the map of epileptogenicity was computed for the group of seizures in order to retain for further correlation with PET data only the ictal SEEG changes that were reproducible between seizures. [11](#epi13592-bib-0011){ref-type="ref"}

The same spectral analysis was systematically performed in the 2--7 Hz and 8--20 Hz bands, situated below the band of quantifying epileptogenicity in all patients. The goal of this second analysis was to confirm the specificity of the correlation between fast activity and hypometabolism, as opposed to a correlation that could be present with any type of recorded electrical activity.

Measure of SEEG/FDG‐PET correlation {#epi13592-sec-0016}
-----------------------------------

The correlation analysis between SEEG ictal power and FDG‐PET was performed on a region of interest (ROI) basis. We used the MNI‐based canonical Destrieux parcellation to define 76 ROIs per hemisphere.[18](#epi13592-bib-0018){ref-type="ref"} In each ROI, only voxels in the gray matter and containing SEEG power values were considered. In other words, we ignored voxels for which both types of information were not available and did not try to predict the whole PET image from spatially limited SEEG recordings. For voxels sampled by SEEG, the average value of PET values (normalized by cerebellum activity, see [FDG‐PET study](#epi13592-sec-0009){ref-type="sec"}) and epileptogenicity values in the different frequency bands (see [SEEG investigation](#epi13592-sec-0012){ref-type="sec"}) were computed. For each patient, the SEEG/FDG‐PET correlation was computed using the Pearson cross‐correlation value of both features averaged in each ROI explored by SEEG electrodes. This approach does not quantify the SEEG/FDG‐PET correlation of the SOZ only, but operates at the level of the whole implanted network. This means that it might suffer from a lack of sensitivity for very focal epilepsies, or if the true ictal onset was missed, but is well adapted to also capture the effects in regions of propagation. According to the hypothesis that PET hypometabolism is correlated with epileptogenic regions, we anticipated finding a significantly negative SEEG/FDG‐PET correlation in high frequencies.

Results {#epi13592-sec-0017}
=======

In this section, first we report the detailed analysis of a single case in order to show how the correlation between SEEG and FDG‐PET is processed. Second we proceed to the group analysis of the SEEG/FDG‐PET correlation.

Case study {#epi13592-sec-0018}
----------

Patient 14 (Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}), a 26‐year‐old, right‐handed female graduate student, started having seizures at the age of 20 years. Her familial and personal history was irrelevant. Seizures proved drug‐resistant from the onset, and occurred in cluster of 1 or 2 days, with seizure‐free intervals of 2--3 weeks. Seizure symptomatology was characterized by an initial loss of contact (no signal symptom), immobility for 30--60 s, short postictal confusion with a few word finding difficulties, and complete amnesia of the episode. Neurologic examination was normal, and neuropsychological evaluation revealed some working memory dysfunctions. Repeated high‐resolution MRI studies did not reveal any abnormalities. A careful visual analysis of FDG‐PET revealed hypometabolism of the left anterior temporal lobe (Fig. [3](#epi13592-fig-0003){ref-type="fig"}A). Functional MRI demonstrated a left predominance for language. During video‐EEG monitoring, interictal spikes were recorded over the left temporal lobe, whereas ictal activity appeared more extended, involving from the onset a large frontal‐centrotemporal area. Based on this information, a left temporoperisylvian SEEG study was judged necessary and 14 intracerebral electrodes were implanted to record activity of the temporal lobe, anterior cingulate gyrus and orbitofrontal cortex, and anterior insula and temporoparietal junction (Fig. [2](#epi13592-fig-0002){ref-type="fig"}C). Six stereotyped seizures were recorded, showing an initial involvement of the temporobasal cortex (T4) and mesiotemporal lobe structures (amygdala, hippocampus, and hippocampal gyrus) (Fig. [2](#epi13592-fig-0002){ref-type="fig"}A), with a secondary spread to the temporal neocortex, insula, and frontobasal cortex. Time‐frequency analysis of power on all seizures showed early high‐frequency oscillations up to 160 Hz in the temporobasal cortex followed by more diffuse, slower, and longer oscillations (Fig. [2](#epi13592-fig-0002){ref-type="fig"}B). The epileptogenicity analysis performed at between 80 and 160 Hz and during the first 4 s of seizures revealed a network involving mesiotemporal structures and temporobasal neocortex (Fig. [2](#epi13592-fig-0002){ref-type="fig"}D). An anteromesial temporal resection (from the temporal pole up to the posterior hippocampus) was performed, and the patient has remained seizure‐free for 44 months, with a mild verbal memory deficit. Pathologic examination showed only signs of nonspecific gliosis.

![Epileptogenicity mapping of patient 14 (see Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}). (**A**) Bipolar SEEG recordings of a seizure in (1) amygdala, (2) anterior parahippocampal gyrus, (3) posterolateral temporal gyrus (T3), (4) anterior hippocampus, and (5) posterior hippocampus. (**B**) Time‐frequency transform of SEEG power of the signals shown in (**A)**. (**C**) Positions of electrodes in patient\'s MRI mesh of cortical surface. Numbers indicate locations of electrodes with signals shown in (**A--B**). (**D**) Epileptogenicity map in 80--160 Hz frequency band. L, left; R, right.](EPI-57-2045-g002){#epi13592-fig-0002}

Using parcellation of Destrieux\'s atlas (Fig. [3](#epi13592-fig-0003){ref-type="fig"}B), we could compute the correlation between PET and SEEG data (Fig. [3](#epi13592-fig-0003){ref-type="fig"}C), which revealed a significant negative cross‐correlation only in the 80--160 Hz frequency band (cc~2--7~ = −0.1223, p~2--7~ = 0.3738; cc~8--20~ = −0.0472, p~8--20~ = 0.7324; cc~80--160~ = −0.3081, p~80--160~ = 0.0263). The negative value of the correlation indicates that regions showing iHFOs showed a tendency for interictal hypometabolism in this patient.

![ROI‐based correlation of FDG‐PET and ictal SEEG power in patient 14 (see Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}). (**A**) FDG‐PET map normalized in the MNI space, showing hypometabolism in the left anterior temporal lobe. L, left; R, right. (**B**) ROI of the Destrieux atlas in the MNI space. (**C**) ROI‐based correlation of FDG‐PET and ictal SEEG power in different frequency bands. Each dot represents for each ROI the values of ictal SEEG power (*t*‐value of the comparison of ictal vs. baseline period) and cerebellum‐normalized FDG‐PET. The lines show the linear regression on the data distribution for each frequency band (significance of correlation: p~2--7~ = 0.3738; p~8--20~ = 0.7324; and p~80--160~ = 0.0263).](EPI-57-2045-g003){#epi13592-fig-0003}

Group study of SEEG/FDG‐PET correlation {#epi13592-sec-0019}
---------------------------------------

On the 37 patients, a total of 115 seizures were processed (from 1 to 10 seizures/patient, on average: 3.1). The frequency band of iHFOs was on average 81--139 Hz (lowest, 30--60 Hz; highest, 160--210 Hz). In the present group analysis, the outcome of visual analysis of FDG‐PET data and of SEEG data was ignored. We considered only the ROI‐based Pearson correlation coefficient of FDG‐PET and ictal SEEG power in different frequency bands, as shown in Figure [2](#epi13592-fig-0002){ref-type="fig"}C. At the group level (Fig. [4](#epi13592-fig-0004){ref-type="fig"}), a significant association was found between the ROIs showing HFOs and FDG‐PET hypometabolism (Mann‐Whitney *U* test, p~2--7~ = 0.5214; p~8--20~ = 0.1818; and p~81--139~ = 0.0021).

![ROI‐based correlation of FDG‐PET and ictal SEEG power for each patient (see Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}) in the different frequency bands.](EPI-57-2045-g004){#epi13592-fig-0004}

Figure [4](#epi13592-fig-0004){ref-type="fig"} suggested that the SEEG/FDG‐PET correlation was more pronounced in patients with TLE (patient 1--15, as could have been anticipated from current knowledge on the overlap of the FDG‐PET hypometabolism and the SOZ[2](#epi13592-bib-0002){ref-type="ref"}, [3](#epi13592-bib-0003){ref-type="ref"}, [4](#epi13592-bib-0004){ref-type="ref"}, [5](#epi13592-bib-0005){ref-type="ref"}). Therefore, we performed the same analysis but separated TLE patients from extra‐TLE patients. Of interest, we found a much higher correlation between SEEG and FDG‐PET hypometabolism in patients with TLE (p~2--7~ = 0.0554; p~8--20~ = 0.0353; p~81--139~ = 0.0020; after Bonferroni correction, only significant in high frequency band at 0.05 significance level) than in patients with extra‐TLE (p~2--7~ = 0.2491; p~8--20~ = 0.3896; p~81--139~ = 0.2360). This effect could not be explained by the choice of the frequency band of HFOs, as no significant difference was found on the mean of the frequency band of interest between the two groups (f~TLE~ = 105 Hz, f~extraTLE~ = 112 Hz, p = 0.4557, Mann‐Whitney *U* test), or by the number of seizures per month (n~TLE~ = 7.8 seizures/month, n~extraTLE~ = 11.3 seizures/month, p = 0.8739, Mann‐Whitney *U* test).

Finally, we checked whether the presence of a focal cortical dysplasia (18/37 patients with confirmed FCD, see Table [1](#epi13592-tbl-0001){ref-type="table-wrap"}) significantly changed the SEEG/FDG‐PET correlation. The similar results between FCD and No FCD cases (FCD: p~2--7~ = 0.9133, p~8--20~ = 0.6475; and p~81--139~ = 0.0429; No FCD: p~2--7~ = 0.4688, p~8--20~ = 0.0329, andp~81--139~ = 0.0196; SEEG/FDG‐PET was correlation significant only in high frequency, after Bonferroni correction) indicated that the presence of an FCD was not discriminant for the SEEG/FDG‐PET correlation.

Discussion {#epi13592-sec-0020}
==========

This study aimed to compare the presence of HFOs at seizure onset, recorded in implanted epilepsy patients, with the interictal patterns of metabolism for each patient. We showed that hypometabolic regions correlate with the presence of iHFOs, in TLE only. This was a consistent finding in a heterogeneous group of patients with focal intractable epileptic seizures, whereas most previous studies using FDG‐PET have been performed in selected patient groups with TLE. The value of FDG‐PET in extra‐TLE has been demonstrated, which warranted studies on the pathophysiology including multiple types of partial epilepsy.[2](#epi13592-bib-0002){ref-type="ref"}, [3](#epi13592-bib-0003){ref-type="ref"} We demonstrated that this correlation in TLE seems specific to iHFOs (\>60 Hz), as no correlation was found when frequencies of 2--7 Hz and 8--20 Hz were selected.

Comparison with other studies {#epi13592-sec-0021}
-----------------------------

Few studies have considered the relationship between the electrical activity during seizures and the metabolic abnormalities in patients with epilepsy. However, this is not a new research question, as Engel et al.[19](#epi13592-bib-0019){ref-type="ref"} studied the relation between FDG‐PET, scalp‐sphenoidal EEG, and intracranial EEG in patients with epilepsy and found a correlation between the electrical and metabolic findings using a qualitative analysis. Lucignani et al.[20](#epi13592-bib-0020){ref-type="ref"} studied the correlation of FDG‐PET and SEEG with quantitative analysis of the FDG‐PET in partial epilepsy. This study found normal metabolic rates in the majority of the areas with abnormal SEEG activity. In the study of Lucignani et al.,[20](#epi13592-bib-0020){ref-type="ref"} 16 ROIs for the FDG‐PET were manually drawn for each patient throughout the brain, and the FDG‐PET was analyzed by averaging the glucose uptake values in the 2--4 ROIs around each electrode. There have been improvements in the analysis of SEEG data since this study was published, and epileptogenicity mapping now allows us to use a quantitative approach to the analysis of the SEEG, by identifying iHFOs. Furthermore, MRI postimplantation of the electrodes allows for precise localization of each electrode and a comparison of the metabolic and electrical findings for each individual voxel, rather than an average of the glucose uptake of multiple larger ROIs around the intracranial electrodes.

Methodologic considerations {#epi13592-sec-0022}
---------------------------

Two specific methodologic considerations must be kept in mind. First, this study was limited by the small spatial sampling of the SEEG, as already pointed out when correlating PET with SEEG data.[21](#epi13592-bib-0021){ref-type="ref"} Ideally, full sampling of the electrical discharges in the brain at seizure onset would help reach a better understanding of the exact correlation of the hypometabolic foci and the epileptogenic zone. SEEG was still the best method to assess electrical activity, as it recorded neuronal electrical activity with the highest precision.[1](#epi13592-bib-0001){ref-type="ref"} Second, although the presence of hypometabolism correlated with iHFOs, it cannot be excluded that it might correlate with other electrical signals. This has been explored in previous studies.[20](#epi13592-bib-0020){ref-type="ref"}, [22](#epi13592-bib-0022){ref-type="ref"} Gnatkovsky et al.[22](#epi13592-bib-0022){ref-type="ref"} have identified three biomarkers from SEEG data that correlate with the EZ: the fast activity at 80--120 Hz, the slow polarizing shift, and the flattening of background activity. Neither the slow polarizing shift nor the flattening of background activity was selected in this study. The relationship between SEEG recorded interictal spikes and FDG‐PET is also of interest but was not investigated. Furthermore, the HFOs are classically defined including frequencies up to 500 Hz,[23](#epi13592-bib-0023){ref-type="ref"} which were not selected in this study because the band of interest was selected based on the activity showing the highest power during the seizure onset, which remained at around 80--140 Hz. This does not exclude the possibility of studying higher frequencies in future studies. The method described earlier was replicable with other types of electrical activity. A better characterization of the specificity of the association between metabolism and other types of electrical activity associated with the epileptogenic zone might be helpful in future studies.

Pathophysiologic implications {#epi13592-sec-0023}
-----------------------------

The presence of a correlation between interictal hypometabolism and iHFOs is not surprising, given previous studies that have demonstrated their individual relationship with epileptogenesis. Of interest, we found that this correlation was present in TLE only. This effect could not be explained by a difference in the frequency band of interest, which on average was the same between the two groups. We could also speculate that this better correlation in TLE is supported by a better spatial sampling by SEEG electrodes of TLE, and that in general it is more likely to miss the true ictal onset in extra‐TLE. However, this fact is not supported by the data of this series, as the ratio of operated patients with an Engel\'s score of I was equivalent between the two groups (TLE: 11/20, 55%; extra‐TLE: 6/11, 54.5%). Because the size of perilesional FDG‐PET abnormalities was shown to correlate with the lifetime number of seizures,[24](#epi13592-bib-0024){ref-type="ref"} we also investigated whether the number of seizures per month was different between the two groups: Although the seizure frequency was higher in extra‐TLE, the difference with TLE was not found to be statistically significant in this series. Finally, we may interpret the observed difference on SEEG/FDG‐PET correlation between TLE and extra‐TLE as a relative lack of specificity for seizure‐onset zone of FDG‐PET in extra‐TLE.[25](#epi13592-bib-0025){ref-type="ref"} Of interest, recent data in the literature indicate a good co‐localization of FDG‐PET with interictal epileptiform activity in extra‐TLE.[26](#epi13592-bib-0026){ref-type="ref"} To go further, one may thus question the co‐localization of ictal HFO and interictal spikes in extra‐TLE.

The relationship between iHFOs and epileptogenesis is well‐established.[27](#epi13592-bib-0027){ref-type="ref"}, [28](#epi13592-bib-0028){ref-type="ref"} Jirsch et al.[23](#epi13592-bib-0023){ref-type="ref"} have shown the presence of iHFOs at seizure onset in a cohort of unselected patients with focal epilepsy occurring mostly in regions of primary epileptogenesis. A meta‐analysis of 11 studies showed that the extent of resection of iHFO‐generating areas, including both ripples and fast ripples, correlates with postsurgical outcome.[29](#epi13592-bib-0029){ref-type="ref"} Other studies indicate a possible role for hypometabolism in epileptogenicity. It is known that hypometabolic foci tend to be larger than the SOZ, and some studies have shown that, in fact, the extent of resection of the tissue that displays hypometabolism on FDG‐PET in temporal lobectomy correlated with surgical outcome.[30](#epi13592-bib-0030){ref-type="ref"} Furthermore, extratemporal hypometabolism in temporal lobe epilepsy was found to be associated with a poorer surgical outcome,[31](#epi13592-bib-0031){ref-type="ref"}, [32](#epi13592-bib-0032){ref-type="ref"}, [33](#epi13592-bib-0033){ref-type="ref"} and the extent of remote hypometabolism has a negative correlation with surgical outcome.[34](#epi13592-bib-0034){ref-type="ref"} These studies, along with our results, may indicate that the hypometabolic foci seen in partial epilepsies are a result of a pathologic process involved in seizure initiation and not just seizure propagation.[9](#epi13592-bib-0009){ref-type="ref"}

This study could not determine a causal relationship between hypometabolism and iHFOs, but it could demonstrate an association specific to TLE. We can only speculate on the mechanisms that could drive a change in metabolism and neuronal networks. The presence of hypometabolism could be a characteristic of the neuronal assemblies generating iHFOs or a sign of injury to surrounding neurons resulting from this process. There is mounting evidence that neurons generating iHFOs in the gamma range undergo significant metabolic changes in order to maintain high activity.[35](#epi13592-bib-0035){ref-type="ref"}, [36](#epi13592-bib-0036){ref-type="ref"} The glucose uptake of these neurons generating excessive iHFOs could be reduced in interictal state, explaining the correlation between iHFOs and interictal hypometabolism. More research on the metabolic alterations resulting from an excessive generation of iHFOs may offer an explanation on the relationship between iHFOs and interictal hypometabolism.

Conclusion {#epi13592-sec-0024}
==========

Overall, this study has shown the need to continue efforts to explain the pathogenesis of hypometabolic foci in patients with intractable epilepsy, as these are related to iHFOs and may help elucidate the pathogenesis of metabolic and electrical changes in epilepsy. This association was found in various forms of TLE from a heterogeneous group of patients, with different types of epilepsy, in complex cases requiring aa SEEG, and including a large portion (22/37) of patients with normal MRI. This suggests that this association may be a core element in the pathogenesis of TLE. Finally, the results demonstrate that FDG‐PET should not be viewed only as a presurgical clinical diagnostic tool, but also as a tool to improve our understanding of the pathogenesis of epilepsy.
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